Evidence map›Paper›PMID 39974664›Full record

ArticleMedComm2025

Noncanonical feedback loop between "RIP3-MLKL" and "4EBP1-eIF4E" promotes neuronal necroptosis.

Shuchao Wang, Yun Zhang, Meijuan Wang, Zhihao Zhai, Yating Tan, Weiye Xu, Xiaozhen Ren, Ximin Hu, Jinyou Mo, Jia Liu and 6 more

Abstract read
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. [Geniposide inhibits retinal cell apoptosis induced by glaucoma through the Hspa1a pathway].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shuchao WangDepartment of Ophthalmology The Second Xiangya Hospital of Central South University Changsha Hunan China.
Yun ZhangNational Clinical Research Center for Mental Disorders The Second Xiangya Hospital of Central South University Changsha Hunan China.
Meijuan WangMedical Imaging Center Qingdao West Coast New District People's Hospital Qingdao Shandong China.
Zhihao ZhaiDepartment of Neurosurgery The Eighth Affiliated Hospital Sun Yat-Sen University Shenzhen China.
Yating TanCenter for Medical Research The Second Xiangya Hospital of Central South University Changsha Hunan China.
Weiye XuDepartment of Anatomy and Neurobiology, Xiangya School of Basic Medical Sciences Central South University Changsha Hunan China.
Xiaozhen RenDepartment of Anatomy and Neurobiology, Xiangya School of Basic Medical Sciences Central South University Changsha Hunan China.
Ximin HuDepartment of Anatomy and Neurobiology, Xiangya School of Basic Medical Sciences Central South University Changsha Hunan China.
Jinyou MoCenter for Medical Research The Second Xiangya Hospital of Central South University Changsha Hunan China.
Jia LiuCenter for Medical Research The Second Xiangya Hospital of Central South University Changsha Hunan China.
Yunfeng YangDepartment of Neurosurgery The Eighth Affiliated Hospital Sun Yat-Sen University Shenzhen China.
Dan ChenDepartment of Anesthesiology The Second Xiangya Hospital of Central South University Changsha Hunan China.
Bing JiangDepartment of Ophthalmology The Second Xiangya Hospital of Central South University Changsha Hunan China.
Hualin HuangNational Clinical Research Center for Mental Disorders The Second Xiangya Hospital of Central South University Changsha Hunan China.
Jufang HuangNational Clinical Research Center for Mental Disorders The Second Xiangya Hospital of Central South University Changsha Hunan China.
Kun XiongDepartment of Anatomy and Neurobiology, Xiangya School of Basic Medical Sciences Central South University Changsha Hunan China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a leading risk factor for disability and death. Necroptosis is involved in stroke pathogenesis. However, the molecular mechanisms underlying necroptosis in stroke remain unclear. The mammalian target of rapamycin complex 1 (mTORC1) modulates necroptosis in the gut epithelium. Eukaryotic translation initiation factor 4E (eIF4E)-binding protein-1 (4EPB1) is one of the main downstream molecules of mTORC1. This study addresses the role of the 4EBP1-eIF4E pathway in necroptosis. The 4EBP1-eIF4E pathway was found to be activated in both necroptotic HT-22 and mouse middle cerebral artery occlusion (MCAO) models. Functionally, 4EBP1 overexpression, eIF4E knockdown, and eIF4E inhibition suppressed necroptosis, respectively. Furthermore, a positive feedback circuit was observed between the 4EBP1-eIF4E and receptor-interacting protein-3 (RIP3)-mixed lineage kinase domain-like protein (MLKL) pathways, in which RIP3-MLKL activates the 4EBP1-eIF4E pathway by degrading 4EBP1 and activating eIF4E. This in turn enhanced RIP3-MLKL pathway activation. The eIF4E activation derived from this loop may stimulate cytokine production, which is a key factor associated with necroptosis. Finally, using a mouse MCAO model, the application of eIF4E, RIP3, and MLKL inhibitors was found to have a regulatory mechanism similar to that in the in vitro study, reducing the infarct volume and improving neurological function in MCAO mice.

Indexed as

4EBP1eIF4EMLKLnecroptosisRIP3stroke

Identifiers

PMID39974664
PMCPMC11836343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.